Source: Eur Respir J , 49 (3) 1602529; DOI: 10.1183/13993003.02529-2016
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nicholas T. Vozoris, Denis E. O'Donnell, Chaim Bell, Sudeep S. Gill, Paula A. Rochon. Incident opioid use is associated with risk of respiratory harm in non-palliative COPD. Eur Respir J , 49 (3) 1602529; DOI: 10.1183/13993003.02529-2016

Member's Comments

No comment yet.

Related content which might interest you: Incident opioid drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J , 49 (3) 1602311; DOI: 10.1183/13993003.02311-2016 Year: 2017 Incident opioid drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2016; 48: 683-693 Year: 2016 Trends in the lifetime risk of COPD exacerbation requiring hospitalisation Source: Eur Respir J 2013; 42: 964-971 Year: 2013 Identifying risk groups for any cause hospitalizations in COPD patients Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Preventative care and home treatment in patients at risk of hospitalisation due to exacerbation of COPD. Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018 Does the provision of home nasal ventilation reduce re-admission rates for patients who were in acute respiratory failure? Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing? Year: 2013 Overuse of short-acting ß2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme Source: Eur Respir J, 55 (4) 1901872; 10.1183/13993003.01872-2019 Year: 2020 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2014; 44: 332-340 Year: 2014 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 566-567 Year: 2015 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 565-566 Year: 2015 Preventing readmission of patients with COPD Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 COPD medications and risk of pneumonia in the UK Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Risk factors contributing to mortality in patients with COPD developing acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen Source: Eur Respir J 2003; 22: Suppl. 45, 375s Year: 2003 Risk factors of mortality in COPD patients with ventilator associated pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 50s Year: 2007 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020